Schrödinger, Inc. (NASDAQ:SDGR) Receives $33.00 Consensus Price Target from Brokerages

Shares of Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) have earned a consensus recommendation of "Buy" from the eight analysts that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $33.00.

SDGR has been the topic of several recent research reports. KeyCorp raised their price target on shares of Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Piper Sandler reduced their target price on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th.

Schrödinger Stock Performance

Shares of NASDAQ SDGR traded up $0.30 during midday trading on Monday, hitting $26.43. 269,830 shares of the stock traded hands, compared to its average volume of 834,058. Schrödinger has a one year low of $16.60 and a one year high of $28.47. The business has a 50 day moving average price of $22.13 and a two-hundred day moving average price of $21.21. The company has a market cap of $1.93 billion, a PE ratio of -11.29 and a beta of 1.77.

Schrödinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.20). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The business had revenue of $88.32 million for the quarter, compared to the consensus estimate of $83.20 million. As a group, equities research analysts forecast that Schrödinger will post -2.37 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Karen Akinsanya sold 16,723 shares of the stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $25.09, for a total transaction of $419,580.07. Following the completion of the transaction, the insider now directly owns 15,625 shares of the company's stock, valued at $392,031.25. This represents a 51.70 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Geoffrey Craig Porges sold 5,491 shares of Schrödinger stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the completion of the sale, the chief financial officer now directly owns 27,544 shares in the company, valued at $599,357.44. This trade represents a 16.62 % decrease in their position. The disclosure for this sale can be found here. 8.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Allspring Global Investments Holdings LLC increased its holdings in Schrödinger by 30.3% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 174,371 shares of the company's stock worth $3,442,000 after acquiring an additional 40,568 shares during the last quarter. Palumbo Wealth Management LLC purchased a new position in shares of Schrödinger in the first quarter worth about $345,000. Stanley Laman Group Ltd. raised its position in shares of Schrödinger by 17.3% in the first quarter. Stanley Laman Group Ltd. now owns 186,980 shares of the company's stock valued at $3,691,000 after purchasing an additional 27,511 shares during the period. Greenwood Capital Associates LLC raised its position in shares of Schrödinger by 2.7% in the first quarter. Greenwood Capital Associates LLC now owns 23,139 shares of the company's stock valued at $457,000 after purchasing an additional 612 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of Schrödinger by 118.5% during the 1st quarter. GAMMA Investing LLC now owns 6,109 shares of the company's stock valued at $121,000 after buying an additional 3,313 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.